Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences

Area of Science:

• Biophysics
• Computational Biology
• Neuroscience

Background:

• Protein aggregation, particularly beta-aggregation, is central to neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Identifying specific protein regions prone to aggregation is crucial for therapeutic development.
• Understanding the structural organization of protein aggregates, like beta-sheets, informs disease transmission mechanisms.

Purpose of the Study:

• To develop and validate a computational model for predicting beta-aggregating peptide sequences.
• To assess the model's ability to predict aggregation rates in natural polypeptide sequences.
• To analyze the model's capacity for identifying aggregation-prone fragments and predicting fibril organization.

Main Methods:

• Utilized physicochemical properties and computational design principles.
• Applied the model to a diverse set of natural polypeptide sequences.
• Evaluated the model's performance in predicting aggregation rates and identifying aggregation-prone segments.

Main Results:

• The model accurately predicts aggregation rates across a wide range of natural polypeptide sequences.
• Successfully identified aggregation-prone fragments within proteins.
• Predicted the parallel or anti-parallel beta-sheet organization within protein fibrils.
• Differentiated aggregation patterns in mammalian and nonmammalian prion proteins, offering insights into prion disease transmission.

Conclusions:

• The developed computational model is a reliable tool for predicting beta-aggregation in proteins.
• This predictive capability is vital for designing targeted therapies for protein deposition diseases.
• The model's insights into prion protein aggregation contribute to understanding interspecies disease transmission barriers.